New Key Statistics Module, Z-Score and F-Score
NAS:LGND Key Ratios
| Market Cap $ M | 1,245.87 |
| Enterprise Value $ M | 1,051.88 |
| P/E(ttm) | 57.25 |
| PE Ratio without NRI | 46.84 |
| Forward PE Ratio | 22.17 |
| Price/Book | 1.92 |
| Price/Sales | 6.38 |
| Price/Free Cash Flow | 11.92 |
| Price/Owner Earnings | 9.84 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 194.00 |
| EPS (TTM) $ | 1.26 |
| Beneish M-Score | -3.89 |
| 10-y EBITDA Growth Rate % | 40.50 |
| 5-y EBITDA Growth Rate % | -3.00 |
| y-y EBITDA Growth Rate % | 28.70 |
| EV-to-EBIT | 9.31 |
| EV-to-EBITDA | 6.58 |
| PEG | -- |
| Shares Outstanding M | 17.27 |
| Net Margin (%) | 12.32 |
| Operating Margin % | 13.65 |
| Pre-tax Margin (%) | 57.41 |
| Quick Ratio | 3.18 |
| Current Ratio | 3.32 |
| ROA % (ttm) | 2.49 |
| ROE % (ttm) | 3.28 |
| ROIC % (ttm) | 1.63 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.43 |
| Piotroski F-Score | 6.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | Y |
LGND Number of Guru Trades
LGND Volume of Guru Trades
Gurus Latest Trades with NAS:LGND
No Available Data
NAS:LGND is held by these investors
Total 2
Ligand Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LGND
Total 0- 1
